SCHEMBL17813623

SCHEMBL17813623

Clc1cc(Cl)cc(-c2cccc(Br)c2)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RXRA P19793 1/20 0.50
RXRB P28702 1/20 0.50
CHKA P35790 1/20 0.43
CNR1 P21554 1/20 0.42
GABRG2 P18507 5/20 0.42
GABRB3 P28472 5/20 0.42
GABRA5 P31644 5/20 0.42
GABRA3 P34903 5/20 0.42
GABRA1 P14867 4/20 0.42
BIRC5 O15392 1/20 0.42
GABRP O00591 1/20 0.41
GABRD O14764 1/20 0.41
GABRB1 P18505 1/20 0.41
GABRA2 P47869 1/20 0.41
GABRB2 P47870 1/20 0.41
GABRA4 P48169 1/20 0.41
GABRE P78334 1/20 0.41
GABRA6 Q16445 1/20 0.41
GABRG1 Q8N1C3 1/20 0.41
GABRG3 Q99928 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2275959 0.89 ALOX5 (0.48) RXRARXRBGABRG2GABRB3GABRA5
SCHEMBL29468118 0.88 ALOX5 (0.52) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29389647 0.88 ALOX5 (0.52) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29397674 0.88 ALOX5 (0.52) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL867900 0.88 ALOX5 (0.52) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL1744049 0.86 ALOX5 (0.50) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL1345303 0.83 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL16675055 0.83 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL29696912 0.83 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA3GABRA1
SCHEMBL16675046 0.83 GABRG2 (0.48) GABRG2GABRB3GABRA5GABRA3GABRA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240341188-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2024-10-10 US disclosed
WO-2016089080-A1 ORGANIC LUMINESCENT COMPOUND AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME 주식회사 두산 2016-06-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240341188-A1 CONDENSED CYCLIC COMPOUND, LIGHT-EMITTING DEVICE INCLUDING THE CONDENSED CYCLIC COMPOUND, AND ELECTRONIC APPARATUS INCLUDING THE LIGHT-EMITTING DEVICE CCNE2, TCEA1, ELP1 RXRA 3434/4885RXRB 3672/4885CHKA 4080/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.